Royal Stoke University Hospital

Stoke-on-Trent, Staffordshire ST4 6QG

3 studies enrolling now · 11 studies all time

What they study most

Acute Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Chronic Cluster Headache, Episodic Cluster Headache, First Line Non-Small Cell Lung Cancer, High-risk Transient Ischemic Attack, Immunoglobulin A Nephropathy (IgAN), Intracerebral Hemorrhage, Moderate to Severe Plaque Psoriasis, Multiple Myeloma, Plaque Type Psoriasis, Prevention of Ischemic Stroke

Studies at this site

• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• MSB11022 in Moderate to Severe Chronic Plaque Psoriasis — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed